Zuckerman, Andrea

ASRM müllerian anomalies classification 2021

Pfeifer, S. M., Attaran, M., Goldstein, J., Lindheim, S. R., Petrozza, J. C., Rackow, B. W., Siegelman, E., Troiano, R., Winter, T., Zuckerman, A., et al. (2021) · Fertility and Sterility

Gynecological conditions and treatmentsSexual Differentiation and Disorders

Cited by 407

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease

Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2008) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 302

Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease: The Treating to New Targets (TNT) Study

Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2007) · Clinical Journal of the American Society of Nephrology

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 275

Cardiovascular risk factors and dementia

Fillit, H., Nash, D. T., Rundek, T., & Zuckerman, A. (2008) · The American Journal of Geriatric Pharmacotherapy

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 225

Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD

Koren, M. J., Davidson, M. H., Wilson, D. J., Fayyad, R. S., Zuckerman, A., & Reed, D. P. (2009) · American Journal of Kidney Diseases

Lipoproteins and Cardiovascular HealthBlood Pressure and Hypertension Studies

Cited by 115